adenosine has been researched along with Nervous System Disorders in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.13) | 18.7374 |
| 1990's | 4 (12.50) | 18.2507 |
| 2000's | 6 (18.75) | 29.6817 |
| 2010's | 15 (46.88) | 24.3611 |
| 2020's | 6 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JF; Fredholm, BB; Masino, SA; Vaugeois, JM | 1 |
| Cheng, X; Huang, X; Li, X; Shu, L | 1 |
| Borea, PA; Contri, C; Gessi, S; Merighi, S; Pasquini, S; Varani, K; Vincenzi, F | 1 |
| Chen, JF; Illes, P; Tang, Y; Ulrich, H | 1 |
| Amblard, F; Bassit, L; Costa, VV; Cox, BD; Del Sarto, JL; Gavegnano, C; Guimarães, MZ; Olmo, IG; Pedrosa, CDSG; Queiroz-Junior, CM; Rehen, S; Ribeiro, FM; Rocha, RPF; Schinazi, RF; Teixeira, MM; Valiate, B; Zhou, L | 1 |
| Costa Cruz, PH; Kawahara, Y | 1 |
| Chokkalla, AK; Mehta, SL; Vemuganti, R | 1 |
| Borea, PA; Gessi, S; Merighi, S; Varani, K; Vincenzi, F | 1 |
| Du, K; Lee, T; Sun, T; Zhang, L | 1 |
| Bebawy, JF; Bendok, BR; DeWood, MS; Gupta, DK; Hemmer, LB; Kim, ES; Koht, A; Ramaiah, VK; Sharma, S; Zeeni, C | 1 |
| Church, GM; Li, JB | 1 |
| Fujiyama, A; Kawabata, H; Mitsuyama, T; Okada, S; Sakurai, M; Suzuki, T; Terajima, H; Toyoda, A; Ueda, H; Yano, T | 1 |
| Chiu, GS; Freund, GG | 1 |
| Aronica, E; Boison, D | 1 |
| Chen, H; Duan, RS; Li, H; Li, XL; Wang, CC; Wang, S; Xu, H; Yang, B; Yue, LT; Zhang, M; Zhang, P | 1 |
| Hundley, HA; Washburn, MC | 1 |
| Aiuti, A; Azzari, C; Baldoli, C; Barzaghi, F; Bianchi, V; Canale, S; Carlucci, F; Carriglio, N; Casiraghi, M; Comi, G; Cominelli, M; D'Adamo, P; Dallatomasina, C; Ferrua, F; Forcellini, CA; Fumagalli, F; Hernandez, RJ; la Marca, G; Leocani, L; Medaglini, S; Minicucci, F; Notarangelo, LD; Poliani, PL; Politi, LS; Riboni, E; Sauer, AV; Sessa, M; Tabucchi, A | 1 |
| Ribeiro, JA; Sebastião, AM | 1 |
| Farajollahi, S; Maas, S | 1 |
| Avram, MJ; Batjer, HH; Bebawy, JF; Bendok, BR; Gupta, DK; Hemmer, LB; Koht, A; Zeeni, C | 1 |
| Decher, N; Streit, AK | 1 |
| Chen, S; Dong, H; Hou, L; Hu, S; Wang, S; Xiong, L; Zhang, H; Zhang, J | 1 |
| de Mendonca, A; Ribeiro, JA; Sebastiao, AM | 1 |
| Boison, D; Pignataro, G; Simon, RP; Studer, FE; Wilz, A | 1 |
| Boison, D | 1 |
| Agarwal, RP; Kufe, DW; Major, PP | 1 |
| Kamen, BA; Quinn, CT | 1 |
| Abbracchio, MP; Brambilla, R; Cattabeni, F; Ceruti, S; Franceschi, C; Jacobson, KA; Malorni, W; von Lubitz, DK | 1 |
| Bechis, G; Berland, Y; Couraud, F; Dussol, B; Guieu, R; Halimi, G; Rochat, H; Sampieri, F; Sampol, J | 1 |
| Cloutier, RL | 1 |
| Kikuchi, T; Kitagawa, H; Mitsumoto, Y; Mori, A; Shimada, J | 1 |
| Shibata, S; Tominaga, K; Watanabe, S | 1 |
20 review(s) available for adenosine and Nervous System Disorders
| Article | Year |
|---|---|
Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs.
Topics: Adenosine; Animals; Central Nervous System; Humans; Mice; Mice, Knockout; Nervous System Diseases; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1 | 2005 |
Emerging Roles of N6-Methyladenosine Modification in Neurodevelopment and Neurodegeneration.
Topics: Adenosine; Animals; Humans; Nerve Degeneration; Nervous System; Nervous System Diseases; Neurogenesis; Synapses | 2021 |
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets.
Topics: Adenosine; Animals; Humans; Mental Disorders; Nervous System Diseases; Receptors, Purinergic P1 | 2022 |
Purinergic receptors in cognitive disturbances.
Topics: Adenosine; Adenosine Triphosphate; Animals; Cognition; Depressive Disorder, Major; Mice; Nervous System Diseases; Receptors, Purinergic | 2023 |
RNA Editing in Neurological and Neurodegenerative Disorders.
Topics: Adenosine; Amyotrophic Lateral Sclerosis; Animals; Epilepsy; Humans; Inosine; Nervous System Diseases; Neurodegenerative Diseases; Phenotype; RNA Editing | 2021 |
Epitranscriptomic regulation by m
Topics: Adenosine; Brain; Circadian Rhythm; Cognition; Epigenomics; Gene Expression Regulation; Humans; Methylation; Nervous System Diseases; Neurogenesis; Neuronal Plasticity; RNA; RNA, Messenger; Stress, Physiological | 2020 |
Pharmacology of Adenosine Receptors: The State of the Art.
Topics: Adenosine; Animals; Autoimmune Diseases; Cardiovascular Diseases; Humans; Molecular Structure; Neoplasms; Nervous System Diseases; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction | 2018 |
m
Topics: Adenosine; Humans; Methylation; Nervous System Diseases; Neurogenesis | 2019 |
Deciphering the functions and regulation of brain-enriched A-to-I RNA editing.
Topics: Adenosine; Animals; Brain; Computational Biology; Genomics; Humans; Inosine; Mutation; Nervous System Diseases; RNA; RNA Editing | 2013 |
Modulation of neuroimmunity by adenosine and its receptors: metabolism to mental illness.
Topics: Adenosine; Animals; Humans; Mental Disorders; Mice; Nervous System; Nervous System Diseases; Receptors, Purinergic P1 | 2014 |
Comorbidities in Neurology: Is adenosine the common link?
Topics: Adenosine; Animals; Comorbidity; Humans; Nervous System Diseases; Neuroglia; Signal Transduction | 2015 |
Caffeine and adenosine.
Topics: Adenosine; Animals; Caffeine; Cognition; Humans; Learning; Mental Disorders; Models, Biological; Nervous System Diseases; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1 | 2010 |
Molecular diversity through RNA editing: a balancing act.
Topics: Adenosine; Animals; Deamination; Humans; Neoplasms; Nervous System Diseases; Proteins; RNA Editing | 2010 |
A-to-I RNA editing modulates the pharmacology of neuronal ion channels and receptors.
Topics: Adenosine; Animals; Humans; Inosine; Ion Channels; Nervous System Diseases; Neurotransmitter Agents; Receptors, Cell Surface; RNA Editing | 2011 |
Participation of adenosine receptors in neuroprotection.
Topics: Adenosine; Drug Design; Humans; Mental Processes; Nervous System Diseases; Neurodegenerative Diseases; Neuronal Plasticity; Receptors, Purinergic P1; Synaptic Transmission | 2003 |
Adenosine as a modulator of brain activity.
Topics: Adenosine; Adenosine Kinase; Animals; Brain; Clinical Trials as Topic; Drug Delivery Systems; Drug Evaluation, Preclinical; Humans; Nervous System Diseases; Receptor, Adenosine A1; Receptor, Adenosine A2A | 2007 |
A biochemical perspective of methotrexate neurotoxicity with insight on nonfolate rescue modalities.
Topics: Acute Disease; Adenosine; Biopterins; Chronic Disease; Folic Acid Antagonists; Homocysteine; Humans; Methotrexate; Nervous System Diseases; Nucleic Acid Synthesis Inhibitors | 1996 |
Modulation of apoptosis by adenosine in the central nervous system: a possible role for the A3 receptor. Pathophysiological significance and therapeutic implications for neurodegenerative disorders.
Topics: Adenosine; Animals; Apoptosis; Astrocytes; Brain; Brain Ischemia; Humans; Nervous System Diseases; Neuroprotective Agents; Receptor, Adenosine A3; Receptors, Purinergic P1; Synaptic Transmission | 1997 |
Adenosine and the nervous system: pharmacological data and therapeutic perspectives.
Topics: Adenosine; Animals; In Vitro Techniques; Nervous System Diseases; Nervous System Physiological Phenomena; Receptors, Purinergic; Receptors, Purinergic P1 | 1998 |
When sepsis is only an appearance.
Topics: Adenosine; Dehydration; Diagnosis, Differential; Electrocardiography; Female; Gastrointestinal Diseases; Heart Diseases; Hematologic Diseases; Humans; Hypoglycemia; Nervous System Diseases; Sepsis; Wolff-Parkinson-White Syndrome | 2001 |
12 other study(ies) available for adenosine and Nervous System Disorders
| Article | Year |
|---|---|
7-Deaza-7-fluoro-2'-C-methyladenosine inhibits Zika virus infection and viral-induced neuroinflammation.
Topics: Adenosine; Animals; Antiviral Agents; Cell Line; Cells, Cultured; Chlorocebus aethiops; Culicidae; Humans; Inflammation; Mice; Nervous System Diseases; Neural Stem Cells; Vero Cells; Viral Load; Virus Replication; Zika Virus; Zika Virus Infection | 2020 |
Adenosine-induced flow arrest to facilitate intracranial aneurysm clip ligation does not worsen neurologic outcome.
Topics: Adenosine; Adult; Aged; Arrhythmias, Cardiac; Case-Control Studies; Cerebrovascular Circulation; Female; Humans; Intracranial Aneurysm; Ligation; Male; Middle Aged; Myocardial Ischemia; Nervous System Diseases; Neurosurgical Procedures; Perfusion; Perioperative Care; Retrospective Studies; Surgical Instruments; Treatment Outcome | 2013 |
A biochemical landscape of A-to-I RNA editing in the human brain transcriptome.
Topics: Adenosine; Adult; Brain; Chromosomes, Human; Energy Metabolism; Gene Expression Profiling; Genome, Human; High-Throughput Nucleotide Sequencing; Humans; Inosine; Models, Genetic; Nervous System Diseases; RNA Editing; RNA, Messenger; Transcription, Genetic; Transcriptome | 2014 |
Activation of the adenosine A2A receptor exacerbates experimental autoimmune neuritis in Lewis rats in association with enhanced humoral immunity.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Cattle; CD4-Positive T-Lymphocytes; Cytokines; Dendritic Cells; Disease Models, Animal; Female; Immunity, Humoral; Immunoglobulin G; Leukocytes, Mononuclear; Lymph Nodes; Lymphocytes; Myelin Sheath; Nervous System Diseases; Neuritis, Autoimmune, Experimental; Phenethylamines; Rats; Rats, Inbred Lew; Receptors, Adenosine A2; Sciatic Nerve | 2016 |
Controlling the Editor: The Many Roles of RNA-Binding Proteins in Regulating A-to-I RNA Editing.
Topics: Adenosine; Adenosine Deaminase; Anemia, Macrocytic; Animals; Base Pairing; Caenorhabditis elegans Proteins; Chromosome Deletion; Chromosomes, Human, Pair 5; Drosophila Proteins; Humans; Inosine; Mice; Nervous System Diseases; Nucleic Acid Conformation; RNA Editing; RNA Splicing; RNA-Binding Proteins; RNA, Double-Stranded; Spliceosomes; Transcriptome | 2016 |
Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients.
Topics: Adenosine; Adenosine Deaminase; Animals; Behavior; Behavior, Animal; Brain; Humans; Mice; Nervous System Diseases | 2017 |
Adenosine-induced flow arrest to facilitate intracranial aneurysm clip ligation: dose-response data and safety profile.
Topics: Adenosine; Adult; Aged; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Female; Humans; Intracranial Aneurysm; Ligation; Male; Middle Aged; Nervous System Diseases; Neurosurgical Procedures; Piperidines; Postoperative Complications; Propofol; Remifentanil; Vasodilator Agents | 2010 |
Noninvasive limb remote ischemic preconditioning contributes neuroprotective effects via activation of adenosine A1 receptor and redox status after transient focal cerebral ischemia in rats.
Topics: Adenosine; Analysis of Variance; Animals; Brain Infarction; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Extremities; Glutathione; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Ischemic Preconditioning; Lipid Peroxidation; Male; Nervous System Diseases; Neuroprotective Agents; Nitrites; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Severity of Illness Index; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Xanthines | 2012 |
Neuroprotection in ischemic mouse brain induced by stem cell-derived brain implants.
Topics: Adenosine; Adenosine Kinase; Alleles; Animals; Brain Ischemia; Cerebral Infarction; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nervous System Diseases; Neurons; Stem Cell Transplantation | 2007 |
Deoxycoformycin: neurological toxicity.
Topics: Adenosine; Adult; Coformycin; Deoxyadenosines; Electroencephalography; Humans; Male; Nervous System Diseases; Pentostatin; Ribonucleosides | 1981 |
Intracerebral adenosine infusion improves neurological outcome after transient focal ischemia in rats.
Topics: Adenosine; Animals; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Female; Injections, Intraventricular; Ischemic Attack, Transient; Male; Microdialysis; Nervous System Diseases; Neurons; Pregnancy; Rats; Rats, Wistar | 2002 |
A neuroprotective effect of adenosine A1-receptor agonists on ischemia-induced decrease in 2-deoxyglucose uptake in rat hippocampal slices.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Brain Ischemia; Deoxyglucose; Hippocampus; In Vitro Techniques; Male; Nervous System Diseases; Phenylisopropyladenosine; Purinergic Antagonists; Rats; Rats, Wistar; Receptors, Purinergic; Theophylline; Vasodilator Agents | 1992 |